How to Stop Taking Suboxone: A Guide to Tapering Safely
Stopping Suboxone requires a supervised tapering protocol — not a cold stop. Buprenorphine withdrawal is real, it is prolonged, and it can be genuinely miserable. But with the right taper schedule, the right timing in your recovery, and real support in place, discontinuation is achievable. The goal is to set yourself up to succeed — not to race to a finish line that doesn’t require racing.
A supervised taper within medication-assisted treatment is the safest way to come off Suboxone.
Why Cold Turkey Is the Wrong Approach
Buprenorphine has a long half-life (24–42 hours) and extremely high receptor affinity. With long-term use, the body adapts to its presence — physical dependence is expected and normal in virtually every MAT patient. This is not the same as addiction. It means stopping abruptly produces a significant withdrawal syndrome. For more on this, see our guide to whether Suboxone shows up on a drug test.
Buprenorphine withdrawal is not life-threatening the way alcohol or benzodiazepine withdrawal can be — but it is prolonged and genuinely severe:
- Flu-like symptoms: muscle aches, sweating, chills, nausea, vomiting, diarrhea
- Insomnia — often the most persistent and disabling symptom, lasting weeks
- Intense physical symptoms of anxiety during withdrawal and emotional dysregulation
- Anhedonia — difficulty feeling pleasure or motivation
- Strong opioid cravings that elevate relapse risk
Acute symptoms typically last 7–14 days. Post-acute symptoms — fatigue, mood instability, sleep disruption, intermittent cravings — can persist for weeks to months.
There is also a safety issue specific to this moment in history: people who stop MAT and relapse are at elevated risk of fatal overdose, because their opioid tolerance has dropped while the fentanyl-dominant drug supply has not changed. The stakes of an unsupported cold stop are higher than they used to be.
The safest path to discontinuation runs through your provider, not around them.
The Supervised Taper: What It Actually Looks Like
No universal schedule works for every person. Providers build the taper around starting dose, duration of treatment, current life stability, and how prior taper attempts have gone.
General framework:
- Reduction increment: Typically 10–25% of the current dose per step
- Reduction interval: Every 1–4 weeks per step, guided by how well each reduction is tolerated
- Starting dose context: Most stable MAT patients are on 8–24mg/day. Higher starting doses require more steps and more time.
The hard truth about the last stretch. Moving from 16mg to 8mg is usually manageable. Moving from 2mg to 0mg is where most people struggle. The lower the dose, the more each milligram matters to receptor occupancy. The hardest part of any taper is the final step — not the first one.
Low-dose buprenorphine (LDB) strategy. Many providers guide patients to sub-milligram doses (0.5mg–0.25mg) before discontinuation. At these doses, compounding pharmacies or film cutting is sometimes used. Allowing receptor adaptation to proceed at these micro-doses reduces the severity of the final withdrawal phase significantly. We cover why Suboxone can make you tired in a separate article.
Clonidine as adjunct. Many providers add clonidine (0.1–0.2mg as needed) during the final taper phases to manage autonomic symptoms — sweating, racing heart, anxiety. It doesn’t eliminate withdrawal, but it substantially reduces its intensity.
Comfort medications. Non-opioid sleep aids (trazodone, hydroxyzine), anti-nausea medications (ondansetron), and antidiarrheals (loperamide) can significantly improve quality of life during the last taper stretch and the discontinuation window. If that applies to you, read more about how long Suboxone blocks opiates.
Post-Acute Withdrawal Syndrome (PAWS): What Comes After
Even after acute buprenorphine withdrawal resolves, many people experience PAWS — a protracted phase of subtler but persistent symptoms:
- Fatigue and low energy persisting for weeks to months
- Sleep disturbances: difficulty falling asleep, vivid dreams, non-restorative sleep
- Emotional flatness or mood swings
- Anhedonia — the inability to feel pleasure from things that used to feel rewarding
- Intermittent, lower-intensity cravings
PAWS is neurobiological, not a character failure. The brain takes time to re-establish normal opioid receptor function and restore natural dopamine signaling after long-term buprenorphine use. People who understand what PAWS is — and that it is time-limited — are far better equipped to navigate it without interpreting the discomfort as a signal to use.
This is the phase where behavioral health support matters most: therapy, peer support, and structured daily activity are not optional during PAWS. They are part of the protocol.
When Is the Right Time to Stop?
Long-term MAT is not a failure. Research consistently shows it reduces mortality, improves functioning, and lowers relapse rates compared to time-limited treatment. There is no medical mandate to discontinue buprenorphine, and “staying on it forever” is a legitimate, evidence-supported option for some people with OUD.
Clinical indicators that tapering may be appropriate to consider:
- At least 1–2 years of sustained recovery: stable sobriety, medication compliance, no emergency episodes
- Strong, stable social support: housing, relationships, structure
- Active engagement in ongoing therapy or peer support — not just MAT appointments
- Low relapse risk as assessed by your provider
- Personal readiness and internal motivation — not external pressure from family, courts, or finances
If you want to stop because someone else wants you to, that is worth exploring with your provider before committing to a taper.
When to Wait
Relapse risk is highest in the 12 months following MAT discontinuation. Pausing the taper conversation may be the right call if:
- You are in the middle of significant life stress: job loss, relationship crisis, housing instability
- Your support network is thin or has recently changed
- You have a history of multiple short-duration relapse cycles
- The motivation to stop is primarily external
There is no shame in staying on buprenorphine longer. The medication supports your life — it is not itself the goal. Work with your provider’s timeline, not against it.
This article is for educational purposes only. Suboxone (buprenorphine/naloxone) requires a prescription and ongoing medical supervision. Contact Trust Psychiatry – Mental Health West Palm Beach at (561) 849-4449 to discuss MAT treatment options. Our team also explains how to maximize Suboxone absorption in detail.
Frequently Asked Questions
How long does a Suboxone taper take?
It depends on starting dose, duration of use, and individual tolerance. Rapid tapers over 1–2 months are rarely successful for long-term MAT patients. Slow tapers over 6–12+ months are more common and more likely to result in sustained discontinuation. Some providers guide patients from high doses to zero over 18–24 months. Slower is almost always safer.
What does buprenorphine withdrawal actually feel like?
The most common description is a prolonged, severe flu with insomnia and emotional volatility. Muscle aches, sweating, restlessness (particularly the “restless legs” sensation), anxiety, nausea, and an inability to sleep are hallmark symptoms. Unlike heroin or short-acting opioid withdrawal, which peaks at 48–72 hours, buprenorphine withdrawal can persist for 2–4 weeks because of the long half-life. Acute symptoms are real. This is not an exaggeration. Learn more about taking gabapentin with Suboxone here.
Can I taper Suboxone without telling my provider?
This is strongly discouraged. Unsupervised tapering removes the safety net — your provider’s ability to slow the taper if you’re struggling, prescribe comfort medications, and adjust the plan. If you relapse during an unsupervised taper, you have no clinical support in place. Involve your provider.
Is there a medication that makes stopping Suboxone easier?
No single medication eliminates buprenorphine withdrawal, but clonidine, trazodone, and hydroxyzine are commonly used adjuncts that manage specific symptoms effectively. Some providers use low-dose naltrexone after buprenorphine has fully cleared as a bridge to opioid antagonist therapy. The right approach depends on your clinical history.
What happens if I relapse after stopping Suboxone?
Relapse does not mean MAT failed — it means OUD is a chronic condition that may need ongoing treatment. Restarting buprenorphine is always an option. Do not let shame prevent you from calling your provider. Returning to MAT promptly after relapse is the clinically correct response, and it may be lifesaving given current drug supply conditions. You may also want to understand who can prescribe Suboxone.
MAT and Tapering Support Across Florida
Stopping Suboxone — when the timing is right and the plan is sound — is a legitimate goal that many people with OUD achieve. At Trust Psychiatry – Mental Health West Palm Beach, Josie Desmarais, PMHNP-BC provides individualized MAT management that includes tapering planning when you’re ready, delivered via telehealth across Florida, including West Palm Beach. Call (561) 849-4449 or contact us online to talk through where you are in your recovery.